Iwao T, Toyonaga A, Oho K, Sakai T, Tayama C, Masumoto H, Sato M, Nakahara K, Tanikawa K
Department of Medicine II, Division of Gastroenterology and Endoscopy, Kurume University School of Medicine, Japan.
J Hepatol. 1997 Jun;26(6):1235-41. doi: 10.1016/s0168-8278(97)80457-6.
BACKGROUND/AIMS: The aim of this prospective study was to examine the association of portal-hypertensive gastropathy and fundal varices in patients with cirrhosis.
We carried out an endoscopic observation in 476 patients with cirrhosis (study 1), including 62 patients undergoing endoscopic obliteration of esophageal varices (study 2). In study 1, patients were classified into five subgroups: no esophagofundal varices (n=119), small esophagofundal varices (n=127), dominant esophageal varices (n=177), dominant fundal varices (n=27), and large esophagofundal varices (n=26). The severity of liver dysfunction was assessed by Pugh-Child classification: class A (n=222), class B (n=200), and class C (n=54). In study 2, two groups, poorly developed fundal varices (n=50) and well developed fundal (n=12), were distinguished and the follow-up endoscopic examinations were performed on the basis of 3-month intervals for 2 years. In each study, the severity of portal-hypertensive gastropathy was scored: 0 (absent), 1 (mild), 2 (severe), and 3 (bleeding).
Study 1: One-way ANOVA showed that both variceal pattern and Pugh-Child class significantly influenced portal-hypertensive gastropathy score. However, two-way ANOVA indicated that variceal pattern was the only significant variable. Portal-hypertensive gastropathy score was significantly higher in patients with dominant esophageal varices than in either patients with no esophagofundal varices or patients with small esophagofundal varices. In contrast, portal-hypertensive gastropathy score in patients with dominant fundal varices was similar to that in patients with no esophagofundal varices and was significantly lower compared with that in patients with dominant esophageal varices. Furthermore, portal-hypertensive gastropathy score was significantly lower in patients with large esophagofundal varices than in patients with dominant esophageal varices. Study 2: After the obliteration of esophageal varices, portal-hypertensive gastropathy score in patients with poorly developed fundal varices became significantly higher at 3-, 6-, 9-months while it was not modified in patients with well developed fundal varices during the follow-up period. Furthermore, the integrated incremental change in portal-hypertensive gastropathy score during the first 1-year follow-up period was significantly lower in patients with well developed fundal varices than in patients with poorly developed fundal varices.
These results indicate that both spontaneous and obliteration-induced portal-hypertensive gastropathy lesions develop less in patients with cirrhosis and fundal varices.
背景/目的:本前瞻性研究旨在探讨肝硬化患者门静脉高压性胃病与胃底静脉曲张之间的关联。
我们对476例肝硬化患者进行了内镜观察(研究1),其中包括62例接受食管静脉曲张内镜下套扎术的患者(研究2)。在研究1中,患者被分为五个亚组:无食管胃底静脉曲张(n = 119)、小食管胃底静脉曲张(n = 127)、显性食管静脉曲张(n = 177)、显性胃底静脉曲张(n = 27)和大食管胃底静脉曲张(n = 26)。通过Pugh-Child分类法评估肝功能损害的严重程度:A类(n = 222)、B类(n = 200)和C类(n = 54)。在研究2中,区分出两组,即胃底静脉曲张发育不良组(n = 50)和胃底静脉曲张发育良好组(n = 12),并在2年的时间里每隔3个月进行一次内镜随访检查。在每项研究中,对门静脉高压性胃病的严重程度进行评分:0分(无)、1分(轻度)、2分(重度)和3分(出血)。
研究1:单因素方差分析显示,静脉曲张类型和Pugh-Child分级均对门静脉高压性胃病评分有显著影响。然而,双因素方差分析表明,静脉曲张类型是唯一的显著变量。显性食管静脉曲张患者的门静脉高压性胃病评分显著高于无食管胃底静脉曲张患者或小食管胃底静脉曲张患者。相比之下,显性胃底静脉曲张患者的门静脉高压性胃病评分与无食管胃底静脉曲张患者相似,且显著低于显性食管静脉曲张患者。此外,大食管胃底静脉曲张患者的门静脉高压性胃病评分显著低于显性食管静脉曲张患者。研究2:食管静脉曲张套扎术后,胃底静脉曲张发育不良患者的门静脉高压性胃病评分在术后3个月、6个月和9个月时显著升高,而胃底静脉曲张发育良好患者在随访期间评分未发生改变。此外,在随访的第1年,胃底静脉曲张发育良好患者的门静脉高压性胃病评分的综合增量变化显著低于胃底静脉曲张发育不良患者。
这些结果表明,肝硬化合并胃底静脉曲张患者自发性和套扎术后门静脉高压性胃病病变的发生较少。